HCPLive

Irritable Bowel Syndrome

Latest Headlines

Novel Treatments Approved for Irritable Bowel Syndrome with Diarrhea
Novel Treatments Approved for Irritable Bowel Syndrome with Diarrhea
The US Food and Drug Association (FDA) granted approval for eluxadoline (Viberzi) and rifaximin (Xifaxan), to treat irritable bowel syndrome with diarrhea (IBS-D) in adult men and women.
Microbiota: Some Bacteria More Painful in IBS
Some intestinal bacteria cause more pain than others in patients with irritable bowel syndrome, according to study results reported by a team of researchers from North Carolina.
Relaxation Responses for Gastrointestinal Disorders
Relaxation responses physiologic states of deep rest induced by practices such as meditation, yoga, and prayer were reported to positively trigger symptom improvement and gene expression changes within patients afflicted with gastrointestinal disorders like irritable bowel syndrome and inflammatory bowel disease.
Diverticulosis and Diverticulitis: When is Surgery Prudent?
Americans’ low-fiber diets that tend to be rich in red meats put them at risk for diverticulosis, and by age 60, roughly half of Americans have or have had diverticulosis. It’s not clear how many patients with diverticulosis go on to develop diverticulitis, but once diverticulitis develops, 10-25% of patients need surgery, often urgently.
Fecal Pills: a New Niche
When NYU Langone Medical Center gastroenterologist Lee Ann Chen, MD needs frozen stool pills, she puts in an order with OpenBiome, a two-year-old Massachusetts non-profit whose sole mission is to provide them.
Putting Fecal Microbiota Transplantation into Practice Part 2
In Part 2 Lea Ann Chen, MD, discusses some potential issues associated with Fecal Matter Transplantation.
Putting Fecal Microbiota Transplantation into Practice
In part one of our interview with Lea Ann Chen, MD, from NYU Langone Medical Center she discusses the practical aspects of Fecal Microbiota Transplantation.

Most Popular

$vacMongoViewPlus$ $vAR$